232 related articles for article (PubMed ID: 19919568)
1. Autoantibody-mediated regulation of B cell responses by functional anti-CD22 autoantibodies in patients with systemic sclerosis.
Odaka M; Hasegawa M; Hamaguchi Y; Ishiura N; Kumada S; Matsushita T; Komura K; Sato S; Takehara K; Fujimoto M
Clin Exp Immunol; 2010 Feb; 159(2):176-84. PubMed ID: 19919568
[TBL] [Abstract][Full Text] [Related]
2. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.
Asano N; Fujimoto M; Yazawa N; Shirasawa S; Hasegawa M; Okochi H; Tamaki K; Tedder TF; Sato S
Am J Pathol; 2004 Aug; 165(2):641-50. PubMed ID: 15277237
[TBL] [Abstract][Full Text] [Related]
3. B cell antigen receptor and CD40 differentially regulate CD22 tyrosine phosphorylation.
Fujimoto M; Kuwano Y; Watanabe R; Asashima N; Nakashima H; Yoshitake S; Okochi H; Tamaki K; Poe JC; Tedder TF; Sato S
J Immunol; 2006 Jan; 176(2):873-9. PubMed ID: 16393971
[TBL] [Abstract][Full Text] [Related]
4. CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse.
Saito E; Fujimoto M; Hasegawa M; Komura K; Hamaguchi Y; Kaburagi Y; Nagaoka T; Takehara K; Tedder TF; Sato S
J Clin Invest; 2002 Jun; 109(11):1453-62. PubMed ID: 12045259
[TBL] [Abstract][Full Text] [Related]
5. Decreased CD22 expression and intracellular signaling aberrations in B cells of patients with systemic sclerosis.
Melissaropoulos K; Liossis SN
Rheumatol Int; 2018 Jul; 38(7):1225-1234. PubMed ID: 29869007
[TBL] [Abstract][Full Text] [Related]
6. Association of CD22 gene polymorphism with susceptibility to limited cutaneous systemic sclerosis.
Hitomi Y; Tsuchiya N; Hasegawa M; Fujimoto M; Takehara K; Tokunaga K; Sato S
Tissue Antigens; 2007 Mar; 69(3):242-9. PubMed ID: 17493148
[TBL] [Abstract][Full Text] [Related]
7. Besides an ITIM/SHP-1-dependent pathway, CD22 collaborates with Grb2 and plasma membrane calcium-ATPase in an ITIM/SHP-1-independent pathway of attenuation of Ca2+i signal in B cells.
Chen J; Wang H; Xu WP; Wei SS; Li HJ; Mei YQ; Li YG; Wang YP
Oncotarget; 2016 Aug; 7(35):56129-56146. PubMed ID: 27276708
[TBL] [Abstract][Full Text] [Related]
8. N-Linked Glycosylation Regulates CD22 Organization and Function.
Wasim L; Buhari FHM; Yoganathan M; Sicard T; Ereño-Orbea J; Julien JP; Treanor B
Front Immunol; 2019; 10():699. PubMed ID: 31019513
[TBL] [Abstract][Full Text] [Related]
9. Association study of B-cell marker gene polymorphisms in European Caucasian patients with systemic sclerosis.
Dawidowicz K; Dieudé P; Avouac J; Wipff J; Hachulla E; Diot E; Tiev K; Cracowski JL; Mouthon L; Amoura Z; Frances C; Carpentier P; Meyer O; Kahan A; Boileau C; Allanore Y
Clin Exp Rheumatol; 2011; 29(5):839-42. PubMed ID: 21961844
[TBL] [Abstract][Full Text] [Related]
10. A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels.
Luo W; Mayeux J; Gutierrez T; Russell L; Getahun A; Müller J; Tedder T; Parnes J; Rickert R; Nitschke L; Cambier J; Satterthwaite AB; Garrett-Sinha LA
J Immunol; 2014 Jul; 193(2):909-920. PubMed ID: 24929000
[TBL] [Abstract][Full Text] [Related]
11. Novel binding site for Src homology 2-containing protein-tyrosine phosphatase-1 in CD22 activated by B lymphocyte stimulation with antigen.
Zhu C; Sato M; Yanagisawa T; Fujimoto M; Adachi T; Tsubata T
J Biol Chem; 2008 Jan; 283(3):1653-1659. PubMed ID: 18024433
[TBL] [Abstract][Full Text] [Related]
12. CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity.
Clark EA; Giltiay NV
Front Immunol; 2018; 9():2235. PubMed ID: 30323814
[TBL] [Abstract][Full Text] [Related]
13. Analysis of tyrosine phosphorylation-dependent interactions between stimulatory effector proteins and the B cell co-receptor CD22.
Yohannan J; Wienands J; Coggeshall KM; Justement LB
J Biol Chem; 1999 Jun; 274(26):18769-76. PubMed ID: 10373493
[TBL] [Abstract][Full Text] [Related]
14. CD22 ligation inhibits downstream B cell receptor signaling and Ca(2+) flux upon activation.
Sieger N; Fleischer SJ; Mei HE; Reiter K; Shock A; Burmester GR; Daridon C; Dörner T
Arthritis Rheum; 2013 Mar; 65(3):770-9. PubMed ID: 23233360
[TBL] [Abstract][Full Text] [Related]
15. B lymphocytes and systemic sclerosis.
Fujimoto M; Sato S
Curr Opin Rheumatol; 2005 Nov; 17(6):746-51. PubMed ID: 16224253
[TBL] [Abstract][Full Text] [Related]
16. CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling.
Sato S; Jansen PJ; Tedder TF
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13158-62. PubMed ID: 9371816
[TBL] [Abstract][Full Text] [Related]
17. The Protein Tyrosine Phosphatase SHP-1 (PTPN6) but Not CD45 (PTPRC) Is Essential for the Ligand-Mediated Regulation of CD22 in BCR-Ligated B Cells.
Alborzian Deh Sheikh A; Akatsu C; Abdu-Allah HHM; Suganuma Y; Imamura A; Ando H; Takematsu H; Ishida H; Tsubata T
J Immunol; 2021 Jun; 206(11):2544-2551. PubMed ID: 33990399
[TBL] [Abstract][Full Text] [Related]
18. Identification of autoantibodies to the I protein of the heterogeneous nuclear ribonucleoprotein complex in patients with systemic sclerosis.
Montecucco C; Caporali R; Cobianchi F; Biamonti G
Arthritis Rheum; 1996 Oct; 39(10):1669-76. PubMed ID: 8843857
[TBL] [Abstract][Full Text] [Related]
19. [B cell abnormalities and autoantibody production in systemic sclerosis].
Sato S
Nihon Rinsho Meneki Gakkai Kaishi; 2006 Apr; 29(2):73-84. PubMed ID: 16651705
[TBL] [Abstract][Full Text] [Related]
20. CD22 and CD72 contribute to the development of scleroderma in a murine model.
Zhao C; Matsushita T; Ha Nguyen VT; Tennichi M; Fujimoto M; Takehara K; Hamaguchi Y
J Dermatol Sci; 2020 Jan; 97(1):66-76. PubMed ID: 31883832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
